HIV Epidemiology

IAS (International AIDS Society) Conference

The Latest

Promo Image

New Data on Tipranavir Highlight the Agent's Benefits

Approximately two years have passed since the initial approval of tipranavir (TPV, Aptivus), yet our knowledge of this agent continues to grow through ongoing research. New findings presented at the 4th International AIDS Society Conference on HIV Pa...